Navigation Links
Equashield Releases Market's Safest Closed System Drug Transfer Device for Medical Professionals
Date:12/9/2013

PORT WASHINGTON, New York, December 9, 2013 /PRNewswire/ --

Equashield (http://www.equashield.com/), the leading provider of Closed System Transfer Devices (CSTD) for hazardous drugs, today announced the launch of Equashield II, the safest closed drug transfer system for medical professionals. Equashield II, the only solution that prevents contamination of syringe plungers by hazardous drugs, represents a breakthrough in medical occupational safety, specifically for pharmacists and nurses.

"We are proud to unveil our second generation, market-leading solution, Equashield II," said Marino Kriheli, Product Manager for Equashield. "Other products on the market offer medical professionals dealing with chemotherapy and other hazardous drugs partial or no protection. By covering more routes of exposure than ever, this product is a truly closed system, and as such, provides medical professionals with unprecedented safety. With its preassembled unique syringe it is also easier and faster to use than any other system, increasing overall hospital productivity."

  • Equashield II is a Closed System Transfer Device with closed pressure equalization and "dry" connectors integrated into a unique syringe. The encapsulated syringe barrel prevents plunger contamination and accidental disconnections. The pre-assembled syringe connects with a single motion to corresponding adaptors for vials, IV bags and tubing.
  • Equashield II is proven to prevent microbial ingress in media-filled vials after repeated inoculation with bacteria and up to 10 vial accesses and transfers, over 7 days of testing, under the most extreme conditions. This provides protection to patients and has demonstrated the potential of extending Beyond Use Dating for single-use or non-preserved drugs, given current USP Chapter 797.
  • Equashield II is the only preassembled syringe on the market that requires no further setup, enabling quicker deployment times than other closed systems.

Equashield's first generation device was initially deployed in 2010 at Cleveland Clinic, and is currently used in more than 200 hospitals and clinics in the U.S. committed to ensuring the safety of medical professionals and patients.

Equashield II was launched at ASHP's Midyear Clinical Meeting, the largest event for pharmacists and pharmacy professionals in the world. Equashield will be exhibiting at the ASHP Meeting through December 11th and can be visited at booth #707.

About Equashield

Equashield is a leading developer of closed system drug transfer devices that protect healthcare professionals from hazardous drug and vapor exposure. EQUASHIELD® is clinically proven to eliminate surface contamination with antineoplastic agents and prevent microbial ingress, having demonstrated the ability to extend beyond-use dating for single-use or non-preserved drugs. The system consists of a unique syringe with encapsulated barrel and plunger, built-in closed pressure equalization, and an integrated single motion connector that remains free of drug residuals after multiple connections. EQUASHIELD® is the only preassembled syringe on the market that requires no further setup, thereby contributing to ease of use and overall hospital productivity. For more information, visit the company's website at http://www.equashield.com/.

Media Contact:
Finn Partners Israel for Equashield
Rachel Glaser
+972-54-250-9439
rachel@finnpartners.co.il


'/>"/>
SOURCE Equashield
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
2. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
3. ShelfX Releases A Fridge That Knows What You Took
4. Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results
5. Stereotaxis Releases V-Sono™ Intracardiac Echocardiography Module for the Vdrive™ Remote Navigation System
6. Simbionix Releases Two New Platforms at the Upcoming DDW and AUA Events
7. Medical Alarm Begins Revenue Recognition from Largest Set of Orders -- Releases New Television Commercial
8. MD Bioproducts releases HLA-B27 subtype specific antibody.
9. ChemDAQ Releases First Sensor For Detection Of Peracetic Acid In Air
10. Polar Releases H7, a Preeminent Wireless Heart Rate Sensor with Bluetooth Smart
11. NanoMarkets Releases New Report on Thin-Film and Printed Batteries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, ... -based mobile pulmonary function testing company, is now able to perform ... developed by ndd Medical Technologies , Inc. ... in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL ... can get any needed testing done in the comfort of her ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released ... failing their residents by lacking a comprehensive, proven plan to eliminate ... a definitive ranking of how states are tackling the worst drug ... only four states – Kentucky , ... Vermont . Of the 28 failing states, three – ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... videos a whole new perspective by using the title layers in ProSlice Levels ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from PsychTests.com ...
Breaking Medicine News(10 mins):